Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Metagenomi (MGX) EBT (2023 - 2025)

Metagenomi (MGX) has disclosed EBT for 3 consecutive years, with -$22.5 million as the latest value for Q4 2025.

  • Quarterly EBT rose 8.58% to -$22.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$87.9 million through Dec 2025, down 5.21% year-over-year, with the annual reading at -$87.9 million for FY2025, 5.21% down from the prior year.
  • EBT for Q4 2025 was -$22.5 million at Metagenomi, down from -$20.6 million in the prior quarter.
  • The five-year high for EBT was -$11.1 million in Q2 2023, with the low at -$25.1 million in Q1 2024.
  • Average EBT over 3 years is -$19.3 million, with a median of -$20.2 million recorded in 2025.
  • The sharpest move saw EBT tumbled 80.45% in 2024, then grew 8.58% in 2025.
  • Over 3 years, EBT stood at -$16.6 million in 2023, then tumbled by 48.52% to -$24.6 million in 2024, then rose by 8.58% to -$22.5 million in 2025.
  • According to Business Quant data, EBT over the past three periods came in at -$22.5 million, -$20.6 million, and -$19.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.